M2M Pharm s.r.o.Active
Key figures
Key figures
2025Balance sheet structure
Summary of annual reports2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Revenue (net turnover) | — | 0 | 213 |
| Profit for the reporting year | — | 0 | -1 246 |
| Retained earnings of previous periods | 0 | 0 | 0 |
| Total assets | 5 000 | 5 000 | 4 918 |
| Total liabilities | 0 | 0 | 1 164 |
| Total equity | 5 000 | 5 000 | 3 754 |
| Calculated dividends | — | — | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Similar companies
Summary: M2M Pharm s.r.o.
Overview
M2M Pharm s.r.o. (IČO 56545002) is a limited liability company (s.r.o.). The company was incorporated in 2024 and has existed for 2 years. Registered office according to the register: Nitra. Main activity according to the Statistical Office: výroba ostatných základných anorganických chemikálií (SK NACE 2013).
People
The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 5 000 €.
Financial results
Revenue for 2025 was 213 €. 2025 ended with a loss of 1 246 €. At the end of 2025 the company had total assets of 4 918 € and equity of 3 754 € (equity ratio 76,3 %).
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 9. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.